Sanger GJ - Search Results

1

Treatment of nausea and vomiting: gaps in our knowledge.

Sanger GJ, Andrews PL. Sanger GJ, et al. Auton Neurosci. 2006 Oct 30;129(1-2):3-16. doi: 10.1016/j.autneu.2006.07.009. Epub 2006 Aug 24. Auton Neurosci. 2006. PMID: 16934536 Review.

2

Neuropharmacology of emesis induced by anti-cancer therapy.

Andrews PL, Rapeport WG, Sanger GJ. Andrews PL, et al. Among authors: sanger gj. Trends Pharmacol Sci. 1988 Sep;9(9):334-41. doi: 10.1016/0165-6147(88)90106-x. Trends Pharmacol Sci. 1988. PMID: 3078093 Review. No abstract available.

3

Abdominal vagal afferent neurones: an important target for the treatment of gastrointestinal dysfunction.

Andrews PL, Sanger GJ. Andrews PL, et al. Among authors: sanger gj. Curr Opin Pharmacol. 2002 Dec;2(6):650-6. doi: 10.1016/s1471-4892(02)00227-8. Curr Opin Pharmacol. 2002. PMID: 12482726 Review.

4

Analysis of pancreatic polypeptide cDNA from the house musk shrew, Suncus murinus, suggests a phylogenetically closer relationship with humans than for other small laboratory animal species.

Hoyle CH, Hill J, Sanger GJ, Andrews PL. Hoyle CH, et al. Among authors: sanger gj. Regul Pept. 2003 Jul 15;114(2-3):137-44. doi: 10.1016/s0167-0115(03)00113-7. Regul Pept. 2003. PMID: 12832102

5

Effect of a selective and potent central nervous system penetrant, neurokinin-3 receptor antagonist (SB-222200), on cisplatin-induced emesis in the ferret.

King AG, Sanger GJ. King AG, et al. Among authors: sanger gj. Neurosci Lett. 2005 Mar 7;376(1):5-8. doi: 10.1016/j.neulet.2004.11.015. Epub 2004 Dec 2. Neurosci Lett. 2005. PMID: 15694264

6

Pica--a model of nausea? Species differences in response to cisplatin.

Liu YL, Malik N, Sanger GJ, Friedman MI, Andrews PL. Liu YL, et al. Among authors: sanger gj. Physiol Behav. 2005 Jun 30;85(3):271-7. doi: 10.1016/j.physbeh.2005.04.009. Physiol Behav. 2005. PMID: 15939445

7

Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin.

Rudd JA, Ngan MP, Wai MK, King AG, Witherington J, Andrews PL, Sanger GJ. Rudd JA, et al. Among authors: sanger gj. Neurosci Lett. 2006 Jan 9;392(1-2):79-83. doi: 10.1016/j.neulet.2005.08.062. Epub 2005 Sep 22. Neurosci Lett. 2006. PMID: 16182445

8

Ghrelin alleviates cancer chemotherapy-associated dyspepsia in rodents.

Liu YL, Malik NM, Sanger GJ, Andrews PL. Liu YL, et al. Among authors: sanger gj. Cancer Chemother Pharmacol. 2006 Sep;58(3):326-33. doi: 10.1007/s00280-005-0179-0. Epub 2006 Jan 25. Cancer Chemother Pharmacol. 2006. PMID: 16435157

9

Behavioural and hypothalamic molecular effects of the anti-cancer agent cisplatin in the rat: A model of chemotherapy-related malaise?

Malik NM, Moore GB, Smith G, Liu YL, Sanger GJ, Andrews PL. Malik NM, et al. Among authors: sanger gj. Pharmacol Biochem Behav. 2006 Jan;83(1):9-20. doi: 10.1016/j.pbb.2005.11.017. Epub 2006 Jan 26. Pharmacol Biochem Behav. 2006. PMID: 16443263

10

Differential effects of dexamethasone, ondansetron and a tachykinin NK1 receptor antagonist (GR205171) on cisplatin-induced changes in behaviour, food intake, pica and gastric function in rats.

Malik NM, Liu YL, Cole N, Sanger GJ, Andrews PL. Malik NM, et al. Among authors: sanger gj. Eur J Pharmacol. 2007 Jan 26;555(2-3):164-73. doi: 10.1016/j.ejphar.2006.10.043. Epub 2006 Oct 28. Eur J Pharmacol. 2007. PMID: 17141213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters